nad has been researched along with Extensively Drug-Resistant Tuberculosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Drlica, K; Singh, A; Zhao, X | 1 |
1 review(s) available for nad and Extensively Drug-Resistant Tuberculosis
| Article | Year |
|---|---|
Fluoroquinolone heteroresistance, antimicrobial tolerance, and lethality enhancement.
Topics: Animals; Anti-Bacterial Agents; Antitubercular Agents; Cysteine; Disinfectants; DNA Gyrase; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Mice; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; NAD; Reactive Oxygen Species; Tuberculosis, Multidrug-Resistant | 2022 |